FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1887653246> ?p ?o ?g. }

• W1887653246 abstract "Background Diabetes has long been recognised as a strong, independent risk factor for cardiovascular disease, a problem which accounts for approximately 70% of all mortality in people with diabetes. Prospective studies show that compared to their non‐diabetic counterparts, the relative risk of cardiovascular mortality for men with diabetes is two to three and for women with diabetes is three to four. The two biggest trials in type 2 diabetes, the United Kingdom Prospective Diabetes Study (UKPDS) and the University Group Diabetes Program (UGDP) study did not reveal a reduction of cardiovascular endpoints through improved metabolic control. Theoretical benefits of the newer peroxisome proliferator activated receptor gamma (PPAR‐gamma) activators like pioglitazone on endothelial function and cardiovascular risk factors might result in fewer macrovascular disease events in people with type 2 diabetes mellitus. Objectives To assess the effects of pioglitazone in the treatment of type 2 diabetes. Search methods Studies were obtained from computerised searches of MEDLINE, EMBASE and The Cochrane Library. Selection criteria Studies were included if they were randomised controlled trials in adult people with type 2 diabetes mellitus and had a trial duration of at least 24 weeks. Data collection and analysis Two authors independently assessed trial quality and extracted data. Pooling of studies by means of random‐effects meta‐analysis could be performed for adverse events only. Main results Twenty‐two trials which randomised approximately 6200 people to pioglitazone treatment were identified. Longest duration of therapy was 34.5 months. Published studies of at least 24 weeks pioglitazone treatment in people with type 2 diabetes mellitus did not provide convincing evidence that patient‐oriented outcomes like mortality, morbidity, adverse effects, costs and health‐related quality of life are positively influenced by this compound. Metabolic control measured by glycosylated haemoglobin A1c (HbA1c) as a surrogate endpoint did not demonstrate clinically relevant differences to other oral antidiabetic drugs. Occurrence of oedema was significantly raised. The results of the single trial with relevant clinical endpoints (Prospective Pioglitazone Clinical Trial In Macrovascular Events ‐ PROactive study) have to be regarded as hypothesis‐generating and need confirmation. Authors' conclusions Until new evidence becomes available, the benefit‐risk ratio of pioglitazone remains unclear. Different therapeutic indications for pioglitazone of the two big U.S. and European drug agencies should be clarified to reduce uncertainties amongst patients and physicians." @default.
• W1887653246 created "2016-06-24" @default.
• W1887653246 creator A5005317798 @default.
• W1887653246 creator A5021516493 @default.
• W1887653246 creator A5025682200 @default.
• W1887653246 creator A5076405762 @default.
• W1887653246 creator A5079939649 @default.
• W1887653246 date "2006-10-18" @default.
• W1887653246 modified "2023-10-17" @default.
• W1887653246 title "Pioglitazone for type 2 diabetes mellitus" @default.
• W1887653246 cites W1513035724 @default.
• W1887653246 cites W1545732697 @default.
• W1887653246 cites W1579924409 @default.
• W1887653246 cites W1606586277 @default.
• W1887653246 cites W1607103841 @default.
• W1887653246 cites W174705705 @default.
• W1887653246 cites W1867945356 @default.
• W1887653246 cites W1891884419 @default.
• W1887653246 cites W1893959718 @default.
• W1887653246 cites W1897237112 @default.
• W1887653246 cites W1915612727 @default.
• W1887653246 cites W1923353159 @default.
• W1887653246 cites W1965124868 @default.
• W1887653246 cites W1965638851 @default.
• W1887653246 cites W1966243777 @default.
• W1887653246 cites W1966656294 @default.
• W1887653246 cites W1967959895 @default.
• W1887653246 cites W1968973887 @default.
• W1887653246 cites W1969102243 @default.
• W1887653246 cites W1970016552 @default.
• W1887653246 cites W1975622853 @default.
• W1887653246 cites W1977428292 @default.
• W1887653246 cites W1979624317 @default.
• W1887653246 cites W1982194579 @default.
• W1887653246 cites W1982990554 @default.
• W1887653246 cites W1986535499 @default.
• W1887653246 cites W1990490378 @default.
• W1887653246 cites W2000378161 @default.
• W1887653246 cites W2000442546 @default.
• W1887653246 cites W2005159576 @default.
• W1887653246 cites W2011430313 @default.
• W1887653246 cites W2014437981 @default.
• W1887653246 cites W2014759828 @default.
• W1887653246 cites W2014971826 @default.
• W1887653246 cites W2015279471 @default.
• W1887653246 cites W2015899437 @default.
• W1887653246 cites W2016901721 @default.
• W1887653246 cites W2017030986 @default.
• W1887653246 cites W2023447984 @default.
• W1887653246 cites W2028038659 @default.
• W1887653246 cites W2033239537 @default.
• W1887653246 cites W2035882325 @default.
• W1887653246 cites W2037447341 @default.
• W1887653246 cites W2039401819 @default.
• W1887653246 cites W2047007084 @default.
• W1887653246 cites W2052245273 @default.
• W1887653246 cites W2053154970 @default.
• W1887653246 cites W2053875005 @default.
• W1887653246 cites W2061303173 @default.
• W1887653246 cites W2062078854 @default.
• W1887653246 cites W2064053453 @default.
• W1887653246 cites W2068237558 @default.
• W1887653246 cites W2069842490 @default.
• W1887653246 cites W2075227327 @default.
• W1887653246 cites W2076964225 @default.
• W1887653246 cites W2078089300 @default.
• W1887653246 cites W2079538046 @default.
• W1887653246 cites W2083725441 @default.
• W1887653246 cites W2085516085 @default.
• W1887653246 cites W2086393043 @default.
• W1887653246 cites W2087271669 @default.
• W1887653246 cites W2090255610 @default.
• W1887653246 cites W2094394439 @default.
• W1887653246 cites W2094798623 @default.
• W1887653246 cites W2102675827 @default.
• W1887653246 cites W2104105195 @default.
• W1887653246 cites W2104785880 @default.
• W1887653246 cites W2104895625 @default.
• W1887653246 cites W2108606693 @default.
• W1887653246 cites W2111184067 @default.
• W1887653246 cites W2112040893 @default.
• W1887653246 cites W2114783994 @default.
• W1887653246 cites W2121776978 @default.
• W1887653246 cites W2121970519 @default.
• W1887653246 cites W2123472586 @default.
• W1887653246 cites W2123946565 @default.
• W1887653246 cites W2125435699 @default.
• W1887653246 cites W2126930838 @default.
• W1887653246 cites W2129416530 @default.
• W1887653246 cites W2129514415 @default.
• W1887653246 cites W2131817499 @default.
• W1887653246 cites W2132196235 @default.
• W1887653246 cites W2132525699 @default.
• W1887653246 cites W2133102549 @default.
• W1887653246 cites W2134293572 @default.
• W1887653246 cites W2136324712 @default.
• W1887653246 cites W2141710858 @default.
• W1887653246 cites W2143674095 @default.
• W1887653246 cites W2144728028 @default.
• W1887653246 cites W2144730453 @default.

• next